References
- Whelan E , AsbridgeM, HaydtS. Representations of oxycontin in North American newspapers and medical journals. Pain Res. Manag.16(4) , 252–258 (2011).
- Kahan M , Mailis-GagnonA, WilsonL, Srivastava A; National Opioid Use Guideline Group. Canadian guideline for safe and effective use of opioids for chronic noncancer pain: clinical summary for family physicians. Part 1: general population. Can. Fam. Physician.57(11) , 1257–1266 (2011).
- Rhodin A , StridsbergM, GordhT. Opioid endocrinopathy: a clinical problem in patients with chronic pain and long term oral opioid treatment. Clin. J. Pain26(5) , 374–380 (2010).
- Compton P , CanamarCP, HillhouseM, LingW. Hyperalgesia in heroin dependent patients and the effects of opioid substitution therapy. J. Pain13(4) , 401–409 (2012).
- Furlan AD , ReardonR, Weppler C; National Opioid Use Guideline Group. Opioids for chronic non cancer pain: a new Canadian practice guideline. CMAJ182(9) , 923–930 (2010).
- Hunter J , Watt-WatsonJ, McGillionM et al. An interfaculty pain curriculum: lessons learned from six years experience. Pain 140(1) , 74–86 (2008).
- Gordon A . Best Practice Guidelines for Treatment of Central Pain After Stroke in Central Neuropathic Pain. Henry JL, Panju AA, Yashpal K (Eds). IASP Press, WA, USA (2007).
- Gordon A . Vulvar pain. The Neurologists View in Female Sexual Pain Disorders: Evaluation and Management. Goldstein I, Pukall C, Goldstein A (Eds). Blackwell, NJ, USA (2009).
- Gourlay DL , HeitHA, AlmahreziA. Universal precautions in pain medicine. Pain Med.6(2) , 107–112 (2005).
- Ewing J . Detecting alcoholism: the CAGE questionnaire. JAMA252(14) , 1905–1907 (1984).
- Webster LR , WebsterRM. Predicting aberrant behaviours in opioid treated patients. Preliminary validation of the opioid risk tool. Pain Medicine6(6) , 432–442 (2005).
- Pink LR , SmithAD, PengP et al. Intake assessment of problematic use of medications in a chronic non cancer clinic. Pain Res. Manag. (2012) (In press).
- Clauw D , McCarbergBH. Managing chronic pain with nonopioid analgesics: a multidisciplinary consult. Am. J. Med.125(5) , S1 (2012).
- Sullivan MJL , BishopSR, PivickJ. The Pain Catastrophizing Scale. Development and validation. Psychological Assessment7(4) , 524–552 (1995).
- Wang C , SchmidCH, RonesRR et al. A randomized trial for tai chi for fibromyalgia. N. Engl. J. Med. 363(8) , 743–754 (2010).
- Kowal J , WilsonKG, GeckCM et al. Changes in perceived pain severity following interdisciplinary treatment for chronic pain. Pain Res. Manag. 16(6) , 451–456 (2011).
- Nickel JC , TrippD, GordonA et al. Update on urologic pelvic pain syndromes: highlights from the 2010 international chronic pelvic pain symposium and workshop, August 29, 2010 Kingston, Ontario, Canada. Rev. Urol. 13(1) , 39–49 (2011).
- Moulin DE , ClarkAJ, GilronI et al. Pharmacologic management of neuropathic pain – consensus statement and guidelines from the Canadian Pain Society Pain. Res. Manag. 12(1) , 13–21 (2007).
- Bril V , EnglandJ, FranklinGM et al. Evidence-based guideline: treatment of painful diabetic neuropathy. Report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation. Neurology 76 , 1758–1765 (2011).
▪ Websites
- IASP. Desirable Characteristics for Pain Treatment Facilities. www.iasp-pain.org/am/template.cfm?section=home&template=/cm/htmldisplay.cfm&contentid=3011
- Centre for Addiction and Mental Health. OxyContin: straight talk. www.camh.net/about_addiction_mental_health/drug_and_addiction_information/oxycontin_straight_talk.html
- Health Canada – Misuse and Abuse of Oxycodone-based Prescription Drugs. www.hc-sc.gc.ca/hc-ps/pubs/precurs/oxycodone/fs-fi/index-eng.php
- Wasser Pain Management Centre. www.mtsinai.on.ca/wasser
- The College of Physicians and Surgeons of Ontario. www.cpso.on.ca
- Neuropathic pain – pharmacological management (CG96). http://guidance.nice.org.uk/cg96